Galectin-3-Independent Prognosis in Heart Failure

Clinical Research in Cardiology - Germany
doi 10.1007/s00392-010-0245-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prognostic Value of Galectin-3 in Patients With Heart Failure

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2015English

The Role of Galectin-3 in Heart Failure and Cardiovascular Disease

Clinical and Experimental Pharmacology and Physiology
PhysiologyPharmacology
2019English

Galectin-3: Clinical Utility and Prognostic Value in Patients With Heart Failure

Research Reports in Clinical Cardiology
2013English

Metabolic Profile Provides Prognostic Value Better Than Galectin-3 in Patients With Heart Failure

Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Usefulness of Plasma Galectin-3 Levels in Systolic Heart Failure to Predict Renal Insufficiency and Survival

American Journal of Cardiology
Cardiovascular MedicineCardiology
2011English

Prognosis in Heart Failure With Preserved Ejection Fraction

sudan heart journal
2017English

Galectin-3 Is Associated With a Poor Prognosis in Primary Hepatocellular Carcinoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

Muscling Up to Improve Heart Failure Prognosis

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Circulating Monocyte Subsets and Heart Failure Prognosis

PLoS ONE
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy